Thrombophilia history and symptoms: Difference between revisions

Jump to navigation Jump to search
(wrote section)
 
(28 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Thrombophilia}}
{{Thrombophilia}}
{{CMG}} {{asiri}}
{{CMG}}; {{AE}} {{asiri}} {{JK}}


==Overview==
==Overview==
A positive family history of [[thrombosis]] and individual recurrent [[thrombosis]] history is suggestive of inherited thrombophilias. Thrombophilia screening may be beneficial in these scenarios.<ref name=DeLoughery>DeLoughery TG. Hemostasis and Thrombosis: Springer International Publishing; 2014.</ref><ref name="pmid24421360">{{cite journal| author=Cohoon KP, Heit JA| title=Inherited and secondary thrombophilia. | journal=Circulation | year= 2014 | volume= 129 | issue= 2 | pages= 254-7 | pmid=24421360 | doi=10.1161/CIRCULATIONAHA.113.001943 | pmc=3979345 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24421360  }} </ref><ref name="pmid11309638">{{cite journal| author=Seligsohn U, Lubetsky A| title=Genetic susceptibility to venous thrombosis. | journal=N Engl J Med | year= 2001 | volume= 344 | issue= 16 | pages= 1222-31 | pmid=11309638 | doi=10.1056/NEJM200104193441607 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11309638  }} </ref>


==History and Symptoms==
==History and Symptoms==
*Inherited thrombophilias should be suspected in following clinical presentations<ref name=?>DeLoughery TG. Hemostasis and Thrombosis: Springer International Publishing; 2014.</ref>:  
*'''Clinical history:<ref name="urlHypercoagulability - StatPearls - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK538251/ |title=Hypercoagulability - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref>'''
**Family history of thrombosis, especially at an early age
**A detailed history consisting of demographics, family history, assessment of risk factors and physical symptoms followed by a standard physical examination is required to differentiate between provoked and unprovoked thromboembolism. A provoking factor is present in up to 70% of patients suffering from venous thromboembolism (VTE).
**Unprovoked thrombosis at an early age (<40-55 for venous thrombosis and <50-55 for arterial thrombosis)
**One in three patients reports a '''positive family history''' predicting the underlying inherited thrombophilia. Hence, patients should be asked specifically if they have a personal history of venous thromboembolism or a family history of venous thrombosis. <ref name="pmid10957782">{{cite journal| author=März W, Nauck M, Wieland H| title=The molecular mechanisms of inherited thrombophilia. | journal=Z Kardiol | year= 2000 | volume= 89 | issue= 7 | pages= 575-86 | pmid=10957782 | doi=10.1007/s003920070206 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10957782  }} </ref>  
**Recurrent thrombosis
**Additional '''acquired risk factors''' should be clearly documented which includes advancing age, a past history of venous thrombosis, immobility, trauma, surgery, nephrotic syndrome, inflammatory disorders, hormone use, pregnancy, post-partum state and obesity.
**Thrombosis at multiple sites, or unusual locations including in cerebral, splanchnic, and renal veins.
**Based on history and physical exam, the '''Wells score''' guides diagnostic workup in first time (VTE) is preferred.
**Thrombosis in arteries with the abscence of arterial disease  
 
**History of fetal loss
*'''Physical signs and symptoms:'''
**The signs and symptoms of thrombosis vary depending on the presumed location and acuity.
**'''Deep Vein Thrombosis (DVT):<ref name="StreiffAgnelli2016">{{cite journal|last1=Streiff|first1=Michael B.|last2=Agnelli|first2=Giancarlo|last3=Connors|first3=Jean M.|last4=Crowther|first4=Mark|last5=Eichinger|first5=Sabine|last6=Lopes|first6=Renato|last7=McBane|first7=Robert D.|last8=Moll|first8=Stephan|last9=Ansell|first9=Jack|title=Guidance for the treatment of deep vein thrombosis and pulmonary embolism|journal=Journal of Thrombosis and Thrombolysis|volume=41|issue=1|year=2016|pages=32–67|issn=0929-5305|doi=10.1007/s11239-015-1317-0}}</ref>'''
***Patients often present with isolated extremity swelling, pain, warmth, and erythema at the site of the blockage and describes the pain as “crampy” located in the calf or thigh of the affected lower extremity or any extremity.
***They may exhibit a decreased range of motion of the extremity, inability to ambulate, or radiation of pain (e.g., into the groin for LE DVT extending to femoral vein).
**'''Acute Pulmonary Embolism (PE):''' <ref name="pmid26780738">{{cite journal| author=Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R | display-authors=etal| title=Guidance for the treatment of deep vein thrombosis and pulmonary embolism. | journal=J Thromb Thrombolysis | year= 2016 | volume= 41 | issue= 1 | pages= 32-67 | pmid=26780738 | doi=10.1007/s11239-015-1317-0 | pmc=4715858 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26780738  }} </ref>
***Patients may present with pleuritic chest pain, shortness of breath, fatigue, back pain, syncope, or even death if severe cases associated with hemodynamic instability or right heart strain.
***Signs include tachycardia, tachypnea, fever, and may include oxygen desaturation.
**'''Arterial thrombosis:''' They are most commonly found in cardiac or cerebrovascular vasculature. <ref name="urlThrombosis - StatPearls - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK538430/ |title=Thrombosis - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref>
***'''Coronary arteries:''' They often report with the classic presentation of “crushing” left-sided chest pain or heaviness with radiation to the left arm or jaw; though atypical presentations can occur frequently.
***'''Cerebral arteries:''' It may present with ischemic stroke symptoms which include acute onset of unilateral or bilateral weakness, headache, confusion, vision changes, dysarthria, dysphagia, paresthesias, difficulty ambulating, or frank paralysis of one or more extremities.
 
'''Table 1: Clinical characteristics of patients with thrombophilia''' <ref>{{cite journal|title=Guidelines on the investigation and management of thrombophilia. The British Committee for Standards in Haematology.|journal=Journal of Clinical Pathology|volume=43|issue=9|year=1990|pages=703–709|issn=0021-9746|doi=10.1136/jcp.43.9.703}}</ref> <ref name="PinjalaReddy2012">{{cite journal|last1=Pinjala|first1=R. K.|last2=Reddy|first2=L. R. C.|last3=Nihar|first3=R. P.|last4=Praveen|first4=G. V. A.|last5=Sandeep|first5=M.|title=Thrombophilia – How Far and How Much to Investigate?|journal=Indian Journal of Surgery|volume=74|issue=2|year=2012|pages=157–162|issn=0972-2068|doi=10.1007/s12262-011-0407-2}}</ref>
 
{| class="wikitable"
|-
! '''Clinical features'''
|-
|
*Unprovoked [[thrombosis]] at an early age (<40-55 for [[venous thrombosis]] and <50-55 for [[arterial thrombosis]])
*Recurrent episodes of thrombosis or thrombophlebitis
*Strong family history of [[thrombosis]] or thrombotic events especially at an early age (< 45 years)
*Thrombosis at multiple or unusual locations including in [[internal cerebral veins|cerebral]], jugular (i.e., Lemierre syndrome), splanchnic, [[hepatic vein|hepatic]], [[portal vein|portal]] (i.e., Budd-Chiari), [[Mesenteric vein thrombosis|mesenteric]], [[renal vein]]s and upper extremity veins.<ref name="pmid21325670">{{cite journal| author=Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP| title=Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences. | journal=Arterioscler Thromb Vasc Biol | year= 2011 | volume= 31 | issue= 3 | pages= 485-93 | pmid=21325670 | doi=10.1161/ATVBAHA.110.213371 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21325670  }} </ref> <ref name="pmid11584361">{{cite journal| author=Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P| title=Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. | journal=Hepatology | year= 2001 | volume= 34 | issue= 4 Pt 1 | pages= 666-70 | pmid=11584361 | doi=10.1053/jhep.2001.27948 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11584361  }} </ref> <ref name="pmid12111785">{{cite journal| author=Bombeli T, Basic A, Fehr J| title=Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. | journal=Am J Hematol | year= 2002 | volume= 70 | issue= 2 | pages= 126-32 | pmid=12111785 | doi=10.1002/ajh.10103 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12111785  }} </ref> <ref name="pmid17768690">{{cite journal| author=Lussana F, Dentali F, Ageno W, Kamphuisen PW| title=Venous thrombosis at unusual sites and the role of thrombophilia. | journal=Semin Thromb Hemost | year= 2007 | volume= 33 | issue= 6 | pages= 582-7 | pmid=17768690 | doi=10.1055/s-2007-985754 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17768690  }} </ref><ref name="pmid29202678">{{cite journal| author=Riva N, Ageno W| title=Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis. | journal=Vasc Med | year= 2017 | volume= 22 | issue= 6 | pages= 529-540 | pmid=29202678 | doi=10.1177/1358863X17734057 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29202678  }} </ref>
*Migratory episodes or diffuse form of thrombotic events
*Severity out of proportion to any recognized known stimulus for thrombosis
*Unexplained neonatal thrombosis or [[miscarriage|fetal loss]]
*Skin necrosis particularly if on coumarins or [[Warfarin_necrosis|warfarin skin necrosis]]
*Unexplained, prolonged, activated partial thromboplastin time
*Patients with idiopathic thrombocytopenia, SLE or recurrent thrombosis including [[deep venous thrombosis]], [[pulmonary embolus]], or [[superficial venous thrombosis]]
*Thrombosis in arteries with the absence of [[Peripheral_arterial_disease|arterial disease]]
|}


==References==
==References==
Line 18: Line 49:


[[Category:Hematology]]
[[Category:Hematology]]
[[Category:FinalQCRequired]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 12:12, 7 April 2021

Thrombophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombophilia history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombophilia history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombophilia history and symptoms

CDC on Thrombophilia history and symptoms

Thrombophilia history and symptoms in the news

Blogs on Thrombophilia history and symptoms

Directions to Hospitals Treating Thrombophilia

Risk calculators and risk factors for Thrombophilia history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2] Jaspinder Kaur, MBBS[3]

Overview

A positive family history of thrombosis and individual recurrent thrombosis history is suggestive of inherited thrombophilias. Thrombophilia screening may be beneficial in these scenarios.[1][2][3]

History and Symptoms

  • Clinical history:[4]
    • A detailed history consisting of demographics, family history, assessment of risk factors and physical symptoms followed by a standard physical examination is required to differentiate between provoked and unprovoked thromboembolism. A provoking factor is present in up to 70% of patients suffering from venous thromboembolism (VTE).
    • One in three patients reports a positive family history predicting the underlying inherited thrombophilia. Hence, patients should be asked specifically if they have a personal history of venous thromboembolism or a family history of venous thrombosis. [5]
    • Additional acquired risk factors should be clearly documented which includes advancing age, a past history of venous thrombosis, immobility, trauma, surgery, nephrotic syndrome, inflammatory disorders, hormone use, pregnancy, post-partum state and obesity.
    • Based on history and physical exam, the Wells score guides diagnostic workup in first time (VTE) is preferred.
  • Physical signs and symptoms:
    • The signs and symptoms of thrombosis vary depending on the presumed location and acuity.
    • Deep Vein Thrombosis (DVT):[6]
      • Patients often present with isolated extremity swelling, pain, warmth, and erythema at the site of the blockage and describes the pain as “crampy” located in the calf or thigh of the affected lower extremity or any extremity.
      • They may exhibit a decreased range of motion of the extremity, inability to ambulate, or radiation of pain (e.g., into the groin for LE DVT extending to femoral vein).
    • Acute Pulmonary Embolism (PE): [7]
      • Patients may present with pleuritic chest pain, shortness of breath, fatigue, back pain, syncope, or even death if severe cases associated with hemodynamic instability or right heart strain.
      • Signs include tachycardia, tachypnea, fever, and may include oxygen desaturation.
    • Arterial thrombosis: They are most commonly found in cardiac or cerebrovascular vasculature. [8]
      • Coronary arteries: They often report with the classic presentation of “crushing” left-sided chest pain or heaviness with radiation to the left arm or jaw; though atypical presentations can occur frequently.
      • Cerebral arteries: It may present with ischemic stroke symptoms which include acute onset of unilateral or bilateral weakness, headache, confusion, vision changes, dysarthria, dysphagia, paresthesias, difficulty ambulating, or frank paralysis of one or more extremities.

Table 1: Clinical characteristics of patients with thrombophilia [9] [10]

Clinical features

References

  1. DeLoughery TG. Hemostasis and Thrombosis: Springer International Publishing; 2014.
  2. Cohoon KP, Heit JA (2014). "Inherited and secondary thrombophilia". Circulation. 129 (2): 254–7. doi:10.1161/CIRCULATIONAHA.113.001943. PMC 3979345. PMID 24421360.
  3. Seligsohn U, Lubetsky A (2001). "Genetic susceptibility to venous thrombosis". N Engl J Med. 344 (16): 1222–31. doi:10.1056/NEJM200104193441607. PMID 11309638.
  4. "Hypercoagulability - StatPearls - NCBI Bookshelf".
  5. März W, Nauck M, Wieland H (2000). "The molecular mechanisms of inherited thrombophilia". Z Kardiol. 89 (7): 575–86. doi:10.1007/s003920070206. PMID 10957782.
  6. Streiff, Michael B.; Agnelli, Giancarlo; Connors, Jean M.; Crowther, Mark; Eichinger, Sabine; Lopes, Renato; McBane, Robert D.; Moll, Stephan; Ansell, Jack (2016). "Guidance for the treatment of deep vein thrombosis and pulmonary embolism". Journal of Thrombosis and Thrombolysis. 41 (1): 32–67. doi:10.1007/s11239-015-1317-0. ISSN 0929-5305.
  7. Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R; et al. (2016). "Guidance for the treatment of deep vein thrombosis and pulmonary embolism". J Thromb Thrombolysis. 41 (1): 32–67. doi:10.1007/s11239-015-1317-0. PMC 4715858. PMID 26780738.
  8. "Thrombosis - StatPearls - NCBI Bookshelf".
  9. "Guidelines on the investigation and management of thrombophilia. The British Committee for Standards in Haematology". Journal of Clinical Pathology. 43 (9): 703–709. 1990. doi:10.1136/jcp.43.9.703. ISSN 0021-9746.
  10. Pinjala, R. K.; Reddy, L. R. C.; Nihar, R. P.; Praveen, G. V. A.; Sandeep, M. (2012). "Thrombophilia – How Far and How Much to Investigate?". Indian Journal of Surgery. 74 (2): 157–162. doi:10.1007/s12262-011-0407-2. ISSN 0972-2068.
  11. Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP (2011). "Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences". Arterioscler Thromb Vasc Biol. 31 (3): 485–93. doi:10.1161/ATVBAHA.110.213371. PMID 21325670.
  12. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P (2001). "Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India". Hepatology. 34 (4 Pt 1): 666–70. doi:10.1053/jhep.2001.27948. PMID 11584361.
  13. Bombeli T, Basic A, Fehr J (2002). "Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems". Am J Hematol. 70 (2): 126–32. doi:10.1002/ajh.10103. PMID 12111785.
  14. Lussana F, Dentali F, Ageno W, Kamphuisen PW (2007). "Venous thrombosis at unusual sites and the role of thrombophilia". Semin Thromb Hemost. 33 (6): 582–7. doi:10.1055/s-2007-985754. PMID 17768690.
  15. Riva N, Ageno W (2017). "Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis". Vasc Med. 22 (6): 529–540. doi:10.1177/1358863X17734057. PMID 29202678.

Template:WH Template:WS